New Harvest Pharm is committed to making medicinal cannabis readily available and affordable for Australian patients by utilising cutting-edge grow house design, automation, and hybrid hydroponic methods. Licensed and ready to start construction
The medicinal cannabis industry has experienced significant growth in recent times, with a 40% increase in authorised prescribers and a rise in SAS-B TGA approvals to 9,602 per month. The average monthly cost for Australian patients has remained stable at $278 for the past 3 years. Additionally, the average price per gram of flower is $17.64, with the lowest being $12.90. New Harvest Pharm is able to produce one gram at a conservative cost of $0.46. Despite a steady increase in patient dosage since 2017, the average patient spending has remained relatively stable. As patient access continues to expand, the demand for cost-effective medication will continue to grow.